Skip to main content
. 2018 Sep;11(9):1301–1310. doi: 10.1016/j.jcmg.2018.06.021

Table 1.

Baseline Characteristics by Guideline Risk Levels

ACC/AHA (2012)
ESC (2013)
NICE (2016)
Complete Trial Cohort
Low Risk High Risk Low Risk High Risk Low Risk High Risk
PROMISE
 Patients 250 9,753 251 9,752 1,002 9,001 10,003
 Age, yrs 55.0 (52.5–57.7) 60.3 (54.6–66.2) 55.0 (52.4–57.7) 60.3 (54.6–66.2) 60.3 (54.3–66.5) 59.9 (54.5–65.9) 60.0 (54.4–65.9)
 Female 250 (100.0) 5,020 (51.5) 251 (100.0) 5,019 (51.5) 564 (56.3) 4,706 (52.3) 5,270 (52.7)
 BMI, kg/m2 30.5 (25.8–35.0) 29.7 (26.4–33.9) 30.4 (25.8–35.0) 29.7 (26.4–33.9) 29.3 (26.0–33.5) 29.7 (26.4–34.0) 29.7 (26.3–33.9)
 Hypertension 152 (60.8) 6,349 (65.1) 153 (61.0) 6,348 (65.1) 611 (61.0) 5,890 (65.4) 6,501 (65.0)
 Hypercholesterolemia 156 (62.4) 6,611 (67.8) 157 (62.5) 6,610 (67.8) 654 (65.3) 6,113 (67.9) 6,767 (67.7)
 Diabetes mellitus 39 (15.6) 2,105 (21.6) 39 (15.5) 2,105 (21.6) 179 (17.9) 1,965 (21.8) 2,144 (21.4)
 Smoking history, current/ex 119 (47.6) 4,985 (51.1) 119 (47.4) 4,985 (51.1) 491 (49.0) 4,613 (51.3) 5,104 (51.0)
 PAD or cerebrovascular disease 7 (2.8) 545 (5.6) 7 (2.8) 545 (5.6) 46 (4.6) 506 (5.6) 552 (5.5)
 Family history 83 (33.3) 3,119 (32.1) 83 (33.2) 3,119 (32.1) 296 (29.6) 2,906 (32.4) 3,202 (32.1)
 Anginal symptoms
 Nonanginal 250 (100) 814 (8.3) 250 (99.6) 814 (8.3) 1,002 (100) 62 (0.7) 1,064 (10.6)
 Atypical angina 0 (0) 7,773 (79.7) 1 (0.4) 7,772 (79.7) 0 (0) 7,773 (86.4) 7,773 (77.7)
 Typical angina 0 (0) 1,116 (12.0) 0 (0) 1,166 (12.0) 0 (0) 1,166 (13.0) 1,166 (11.7)
 Framingham 10-year CVD risk 8.7 (5.9–12.9) 17.4 (10.8–28.9) 8.7 (5.8–12.9) 17.4 (10.8–28.9) 15.6 (9.8–26.0) 17.3 (10.6–28.9) 17.1 (10.6–28.6)
SCOT-HEART
 Patients 528 3,242 748 3,022 1,447 2,323 3,770
 Age, yrs 50.0 (42.0–54.0) 59.0 (51.0–65.0) 51.0 (46.0–58.0) 59.0 (51.0–66.0) 54.0 (47.0–61.0) 59.0 (52.0–66.0) 57.0 (50.0–64.0)
 Female 465 (88.1) 1,256 (38.7) 727 (97.2) 994 (32.9) 669 (46.2) 1,052 (45.3) 1,721 (45.6)
 BMI, kg/m2 29.2 (25.0–34.5) 28.7 (25.7–32.5) 29.1 (25.0–34.6) 28.7 (25.7–32.4) 28.4 (25.1–32.7) 29.0 (25.9–32.9) 28.8 (25.6–32.8)
 Hypertension 112 (21.5) 1,099 (34.2) 179 (24.2) 1,032 (34.4) 362 (25.3) 849 (36.8) 1,211 (32.4)
 Hypercholesterolemia 176 (33.3) 1,902 (58.7) 284 (38.0) 1,794 (59.4) 580 (40.1) 1,498 (64.5) 2,078 (55.1)
 Diabetes mellitus 38 (7.2) 332 (10.2) 58 (7.8) 312 (10.3) 115 (7.9) 255 (11.0) 370 (9.8)
 Smoking history, current/ex 270 (51.1) 1,684 (52.0) 384 (51.3) 1,570 (52.0) 736 (50.9) 1,218 (52.5) 1,954 (51.9)
 PAD or cerebrovascular disease 14 (2.7) 150 (4.7) 22 (3.0) 142 (4.7) 52 (3.6) 112 (4.8) 164 (4.4)
 Family history 251 (47.8) 1,307 (40.7) 353 (47.6) 1,205 (40.3) 580 (40.6) 978 (42.4) 1,558 (41.7)
 Anginal symptoms
 Nonanginal 528 (100.0) 1,088 (33.6) 642 (85.8) 974 (32.2) 1,447 (100.0) 169 (7.3) 1,616 (42.9)
 Atypical angina 0 (0.0) 893 (27.5) 106 (14.2) 787 (26.0) 0 (0.0) 893 (38.4) 893 (23.7)
 Typical angina 0 (0.0) 1261 (38.9) 0 (0.0) 1261 (41.7) 0 (0.0) 1,261 (54.3) 1,261 (33.4)
 Framingham 10-yr CVD risk 6.3 (3.6–9.3) 16.2 (10.0–25.2) 7.4 (4.2–11.2) 16.8 (10.3–25.9) 11.2 (6.6–18.2) 16.7 (9.6–27.0) 14.3 (8.4–23.5)

Values are n, median (interquartile range), n (%), mean ± SD.

ACC/AHA = American College of Cardiology/American Heart Association; BMI = body mass index; CVD = cerebrovascular disease; ESC = European Society of Cardiology; NICE = National Institute of Health and Care Excellence; PAD = peripheral arterial disease; PROMISE = Prospective Multicenter Imaging Study for Evaluation of Chest Pain; SCOT-HEART = Scottish Computed Tomography of the Heart.